Advanced in Biological Technology

Next Safety Releases Advanced Respirator for Infectious Diseases

JEFFERSON, N.C., Aug. 5 /PRNewswire/ -- Next Safety, Inc. (NSI) announces advanced respirators that give people more confidence to go to work in a pandemic environment. Next Safety is releasing for sale to the public respirator products the company developed for the bird flu influenza A ...

Novavax Announces Selection of a Respiratory Syncytial Virus Vaccine Candidate for Advanced Preclinical Studies

ROCKVILLE, Md., July 22 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ) announced today final selection of a Respiratory Syncytial Virus (RSV) vaccine candidate that will be advanced into additional preclinical studies to support an Investigational New Drug (IND) applicati...

Enerkem Announces World-Class Advanced Energy Research Center in Edmonton, Alberta, Canada

Positioning Enerkem at the forefront of advanced energy research MONTREAL, July 7 /PRNewswire/ - Enerkem, a leading waste-to-biofuels and green chemicals technology company, today announced that it will jointly form an advanced energy research center with the City of Edmonton and the Alberta ...

Unexpectedly long-range effects in advanced magnetic devices

A tiny grid pattern has led materials scientists at the National Institute of Standards and Technology (NIST) and the Institute of Solid State Physics in Russia to an unexpected findingthe surprisingly strong and long-range effects of certain electromagnetic nanostructures used in data storage. Th...

UCF team's advanced nerve cell system could help cure diabetic neuropathy, related diseases

Multiple sclerosis, diabetic neuropathy, and other conditions caused by a loss of myelin insulation around nerves can be debilitating and even deadly, but adequate treatments do not yet exist. That's in large part because of deficiencies in model research systems. In an upcoming issue of the journ...

Visage Imaging to Provide Visage(R) CS Enterprise Wide Advanced Visualization Solutions to Advanced Radiology Consultants

ANDOVER, Mass., June 3 /PRNewswire/ -- Visage Imaging(R), Inc., a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), announced today it was selected by Advanced Radiology Consultants to provide its enterprise-wide Visage(R) CS. Based in southern Fairfield County, Connecticut, Advanced Ra...

Abbott & BioGenex Extend the Technology Co-development and Distribution Agreement for Marketing the Xmatrx(R) Advanced Staining Platform for the Automation of FISH, IHC and ISH Molecular Diagnostic Assays

SAN RAMON, Calif., June 2 /PRNewswire/ -- BioGenex, a developer of innovative instruments and reagents for automated slide based staining systems for molecular diagnostics, announced today that Abbott has entered into a definitive agreement to extend the technology co-development and distribution ...

Mersana Reports Preliminary Phase 1 Results of XMT-1001 in Patients with Advanced Solid Tumors

- Results Presented at American Society of Clinical Oncology (ASCO) Meeting Show Fleximer(R) Conjugated Drug Is Well Tolerated with Favorable Pharmacokinetics and Prolonged Stable Disease in Refractory Tumors - CAMBRIDGE, Mass., June 1 /PRNewswire/ -- Mersana Therapeutics presented preliminar...

OncoGenex Pharmaceuticals Announces OGX-011 Treatment Provides Survival Benefit in Randomized Phase 2 Trial in Advanced Metastatic Prostate Cancer

Webcast at 7:10 p.m. Eastern Time Today BOTHELL, WA, and VANCOUVER, May 30 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI ) today announced the final results of a Randomized Phase 2 Trial presented during an oral presentation at the American Society of Clinical Oncol...

Visual i/o Combines Advanced Dynamic Visual Business Intelligence and Search Through New Software

Interactive data visualization and search augments Cognos BI for faster and better business analysis, reporting and decision-making Orlando, FL (PRWEB) May 13, 2009 -- Visual i/o ( www.visual-io.com ) today announced and unveiled the newest generation of its enterprise...

OncoGenex Receives Confirmation from FDA on the Design of a Second Phase 3 Trial Evaluating OGX-011 for the Treatment of Advanced Prostate Cancer

FDA confirms durable pain palliation as an acceptable primary endpoint for a regulatory submission in support of market approval BOTHELL, WA, April 28 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI ) announced today that the company has reached an agreement...

ULURU to Present Clinical Evidence and Advanced Research on Altrazeal at the Society for Advance Wound Care Conference for 2009

ADDISON, Texas, April 23 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Amex: ULU ) announced today that clinical evidence on the treatment of wounds using Altrazeal(TM) along with pre-clinical and physical data on Altrazeal(TM) and Altrazeal(TM) Silver will be presented at the annual Society ...

Fate Therapeutics and Stemgent Launch Catalyst: A Unique Industry Program for First Access to the Most Advanced Induced Pluripotent Stem Cell Technology

Catalyst to Provide Proprietary Protein and Small Molecule Products for the Generation and Differentiation of Genomically-Unaltered Induced Pluripotent Stem (iPS) Cells LA JOLLA, Calif. and BOSTON, April 23 /PRNewswire/ -- Fate Therapeutics, Inc. and Stemgent, Inc. announced today the...

Environmental Tectonics Corporation Exhibiting at the Annual Symposium on Advanced Wound Care and Wound Healing Society

SOUTHAMPTON, Pa., April 23 /PRNewswire-FirstCall/ -- Environmental Tectonics Corporation (NYSE ALTERNEXT US: ETC) ("ETC" or the "Company") today announced that their BioMedical Division will be exhibiting at the upcoming 22nd Annual Symposium on Advanced Wound Care and Wound Healing Society (SAWC/...

AEterna Zentaris Presents Phase 1 Results for AEZS-112 in Patients with Advanced Cancer and Lymphoma at AACR Annual Meeting in Denver

QUEBEC CITY, April 22 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS ), a global biopharmaceutical company focused on endocrine therapy and oncology, today presented a poster outlining Phase 1 results for its orally-active tubulin and topoisomerase II inhibitor compound, ...

World BioBank(TM) Launch Benefits Advanced Medical Research

Human Tissue Collection and Specimen Management Provide Focus MEMPHIS, Tenn., April 22 /PRNewswire/ -- World BioBank(TM), founded by the physician partners of Accelerated Community Oncology Research Network, Inc. (ACORN) and based in Memphis, TN (USA), has begun acquiring human tissue samples...

SIRO ClinPharm and Advanced Clinical Trial Solutions Ink Strategic Alliance

Alliance provides global oncology clinical development solutions in North America, Europe and India. PRINCETON, N.J., April 17 /PRNewswire/ -- SIRO ClinPharm (SIRO), a leading multinational Contract Research Organization (CRO), today announced the signing of a strategic alliance with Advan...

NexBio Completes Clinical Advisory Board for the Advanced Development of DAS181 (Fludase(R)*), a First-In-Class Medicine for Influenza

SAN DIEGO, April 15 /PRNewswire/ -- NexBio, Inc. announced today that it has completed the formation of a new Clinical Advisory Board (CAB) to complement its existing group of Senior Advisers. NexBio recently completed a First-In-Man clinical trial of DAS181 (Fludase(R)), an investigational d...

PROVENGE Significantly Prolongs Survival in Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study

- Study Meets Primary Endpoint Showing Statistically Significant Improvement in Overall Survival - - First Active Immunotherapy for Cancer to Prolong Survival - - Full Data to be Presented at Plenary Session at Upcoming AUA Annual Meeting - - Company to Host a Conference Call Today ...

The Journal of Cardiac Failure Publishes Results From Celladon Corporation's First-in-Human Phase 1/2 Clinical Trial in Advanced Heart Failure

Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID Trial) Demonstrated Safety and Biological Effects of SERCA2a Enzyme Replacement Using Gene Transfer SAN DIEGO, April 8 /PRNewswire/ -- Celladon Corporation today announced the publication of results ...

METTLER TOLEDO and AAPS: Utilization of Process Modeling and Advanced Process Control in QbD based Drug Development and Manufacturing

METTLER TOLEDO invites you to view our latest particle characterization technologies at the American Association of Pharmaceutical Scientists (AAPS) Workshop: Utilization of Process Modeling and Advanced Process Control in QbD based Drug Development and Manufacturing. C...

Roche to Introduce New LightCycler(R) MRSA Advanced Test in the EU

New test for detection of methicillin-resistant Staphylococcus aureus for better patient care PLEASANTON, Calif., April 2 /PRNewswire/ -- Roche announced today that its new LightCycler(R) test for the detection of methicillin-resistant Staphylococcus aureus (MRSA) is now available with the ...

iCardiac Applies Advanced Cardiac Safety Biomarkers in Clinical Study for Top Pharmaceutical Company

Study Includes iCardiac's Highly Automated QT(sm) Solution Rochester, New York (PRWEB) April 1, 2009 -- iCardiac Technologies announced today that its advanced cardiac safety biomarkers were used successfully in a clinical study to model the effect of a serious disease ...

New White Paper Examines Advanced Mycoplasma Tests - How Real-Time PCR Analysis Helps Save Time and Money for Biopharmaceutical Manufacturers

AGAWAM, Mass., March 16 /PRNewswire/ -- Contamination by mycoplasmal organisms is an ever-present concern in biopharmaceutical manufacturing. Their properties make them ready sources of contamination, while rendering them difficult and time-consuming to detect. A new free white paper, examines how...

Leading Middle East Cancer Hospital Acquires Advanced Radiotherapy Capability from Varian Medical Systems

Only Radiotherapy Department in State of Qatar to Introduce State-of-the-Art Treatments including RapidArc(TM) Technology DOHA, Qatar, March 11 /PRNewswire-FirstCall/ -- One of the leading cancer centers in the Middle East has acquired two advanced radiotherapy devices from Varian Medical Sys...

Sigma-Aldrich Streamlines Access to Advanced Stem Cell Research Portfolio and Opens Stem Cell Biology Community Through New Web Portal

Regenerative Medicine Team Put in Place to Serve Future Requirements of Stem Cell Researchers ST. LOUIS, March 11 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL ) today announced the launch of an online web portal that provides researchers with immediate access to its extensive portf...

ClearTrial Launches Version 2.7 of its Clinical Trial Operations Planning Software Featuring Advanced Portfolio Planning Capability

In ClearTrial v2.7, the newest version of the award-winning clinical trial software, ClearTrial introduces Portfolio Planning capability which enables clinical development organizations to roll up protocol-level study plans into portfolio-level forecasts in minutes. The software provides instant...

Sirion Therapeutics Partners With Advanced Vision Research (TheraTears(R)) to Promote Products for Retinal and Meibomian Gland Health

TAMPA, Fla., Feb. 16 /PRNewswire/ -- Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, today announced that it has entered into an agreement with Advanced Vision Research, Inc. (AVR) of Woburn, MA, to co-promote, within the U.S., AVR's new MacuTrition(R) ora...

Nasdaq Panel Grants Advanced Life Sciences Request for Continued Listing on Nasdaq Stock Market

CHICAGO, Feb. 5 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (Nasdaq: ADLS ), today announced that on February 2, 2009 it received a letter from the Nasdaq Listing Qualifications Panel (the "Panel") informing the Company that the Panel has determined to grant the Company's r...

Sopherion Therapeutics, LLC Announces Publication of Phase I/II Myocet(R) (Nonpegylated Liposomal Doxorubicin) Data in Advanced Breast Cancer Patients

PRINCETON, N.J., Feb. 5 /PRNewswire/ -- Sopherion Therapeutics, LLC, a biopharmaceutical company focused on the development and commercialization of anti-cancer therapies, today announced the publication of data from a phase I/II study of nonpegylated liposomal doxorubicin (Myocet(R)) in the Janua...

Queensland Facility for Advanced Bioinformatics (QFAB) Becomes a GeneGo Center of Excellence for the Asia Pacific Region

ST. JOSEPH, Mich., Feb. 2 /PRNewswire/ -- GeneGo, Inc., the leading systems biology tools company, announced today that QFAB has licensed MetaCore and entered a co marketing agreement with GeneGo for the Asia Pacific region. QFAB will have GeneGo certified experts on staff to run training classes...

Pioneering Cancer Center Introduces Advanced Varian RapidArc(TM) Treatments for Cancer Patients in Central Germany

NORDHAUSEN, Germany, Jan. 26 /PRNewswire-FirstCall/ -- Three prostate cancer patients have become the first people in Germany to be treated using a new, faster form of radiotherapy that potentially enables doctors to improve outcomes while extending more advanced care to more patients. Sudharz...

Jubilant Biosys Launches Legend NGSS(TM) Advanced Software Solution for High-Throughput Drug Molecule Screening

NOIDA, India, Jan. 21 /PRNewswire/ -- Jubilant Organosys Ltd, headquartered in Noida near New Delhi, announced today that its subsidiary Jubilant Biosys Ltd., based in Bangalore, has developed a next generation screening solution, Legend NGSS(TM), that will further enable the process of high t...

Micell Forges Strategic Agreement to Develop Advanced Drug-Eluting Stents and Balloons

Company In-licenses State-of-the-art CE-Marked Cobalt-Chromium Coronary Stent Forms Alliance to Jointly Develop Drug Eluting Balloon Products RALEIGH, N.C., Jan. 12 /PRNewswire/ -- Micell Technologies announced today that that the company entered into a strategic agreement with Maxcor In...

Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO)

ABBOTT PARK, Ill. and SANTA ANA, Calif., Jan. 12 /PRNewswire-FirstCall/ -- Abbott ( NYSE: ABT ) and Advanced Medical Optics (AMO) (NYSE: EYE ) announced today a definitive agreement for Abbott to acquire AMO for $22 per share in cash, for a total transaction value of approximately $2.8 bil...

Minimally Invasive Surgery: Olympus Further Enhances Credentials by Entering Into Exclusive Sales and Distribution Partnership With Market and Technology Leader Advanced Surgical Concepts

HAMBURG, Germany, December 11 /PRNewswire/ -- Olympus has further cemented its position as a leader in the field of minimally invasive surgery by signing an exclusive and immediate deal to distribute the products of Irish company Advanced Surgical Concepts worldwide. ASC is the sole global provide...

Imaging Diagnostic Systems is Recognized for Its Advanced Engineering in Time-Resolved Techniques by the US Patent Office

FORT LAUDERDALE, Fla., Nov. 24 /PRNewswire-FirstCall/ -- Imaging Diagnostic Systems, Inc., (OTC Bulletin Board: IMDS) a pioneer in laser optical breast imaging systems, is pleased to announce the issuance of its 21st US Patent entitled "Apparatus and Method for Acquiring Time-Resolved Measurements...

Global Med Technologies(R), Inc. Partners With Biomedical Synergies to Offer Advanced Tissue Tracking Solutions for Hospitals and Surgery Centers

Proven human tissue/implant tracking solution now available internationally DENVER, Nov. 4 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. ("Global Med") (OTC Bulletin Board: GLOB), an international e-Health, medical information technology company, and Biomedical Synergies, Inc. (...

New Clinical Studies Presented at the American Society of Anesthesiology (ASA) Annual Meeting Show Masimo Technologies Provide Advanced Clinical Intelligence

Masimo's Commercial Exhibit Draws More Than 2,500 Conference Attendees IRVINE, Calif., Oct. 23 /PRNewswire-FirstCall/ -- Masimo, the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that 13 new independent and objective clinical st...

Solos Endoscopy, Inc. Applauds American College of Surgeons Review of Advanced Breast Cancer Detection at 94th Annual Clinical Congress

BOSTON, Oct. 23 /PRNewswire-FirstCall/ -- Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce that advanced breast cancer detection through the use of mammary ductoscopy was a featured topic and reviewed in panel discussions at the 94th Annual American College of Surgeons Clinical...